Legal Opinion
Amgen Inc. v. Sandoz Inc.
Court of Appeals for the Federal Circuit
Decided December 14, 2017No. 2015-1499PublishedCited by 15 opinions
1Opinion of the Court
LOURIE, Circuit Judge.
This appeal has returned to us on remand from the Supreme Court of the United States. In their earlier appearance in this court, Amgen Inc. and Amgen Manufacturing Ltd. (collectively, “Amgen”) appealed from the decision of the United States District Court for the Northern District of California (1) granting partial judgment on the pleadings to Sandoz Inc. (“Sandoz”) on its counterclaims seeking a declaratory judgment interpreting the Bio-logies Price Competition and Innovation Act of 2009 (“BPCIA”), Pub. L. No. 111-148, §§ 7001-7003, 124 Stat. 119, 804-21 (2010)…
2Cases cited30 opinions
- Singleton v. WulffSupreme Court of the United States · 1976
- Rice v. Santa Fe Elevator Corp.Supreme Court of the United States · 1947
- Gunn v. MintonSupreme Court of the United States · 2013
- Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
- English v. General Electric Co.Supreme Court of the United States · 1990
25 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Amgen Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2019
- Spears v. ConsultingDistrict Court, M.D. Florida · 2018
- Amgen Inc. v. Hospira, Inc.District Court, D. Delaware · 2018
- Assoc. for Accessible Medicines v. BecerraDistrict Court, E.D. California · 2022
- Beres v. United StatesUnited States Court of Federal Claims · 2019
10 more not listed; retrieve them via the Exa API.